Itxa/189/2015 Of The Commissioner Of Income Tax-11 v. M/S. Aventis Pharma Ltd. (Presently Known As Sanofi India Ltd.)
High Court
31 Jul 2017 In favour of: Assessee
Forum / Bench
High Court · newos
Parties
Itxa/189/2015 Of The Commissioner Of Income Tax-11 v. M/S. Aventis Pharma Ltd. (Presently Known As Sanofi India Ltd.)
Date of order
31 Jul 2017
Assessment year(s)
2001-2002, 2000-01
Outcome
Dismissed
Case summary
In Itxa/189/2015 Of The Commissioner Of Income Tax-11 v. M/S. Aventis Pharma Ltd. (Presently Known As Sanofi India Ltd.), the High Court (2017) dismissed the appeal. The decision went in favour of the assessee.
Summary auto-generated from the order below — read the full judgment for the complete reasoning.
The order — as passed by the High Court
IN THE HIGH COURT OF JUDICATURE AT BOMBAY
ORDINARY ORIGINAL CIVIL JURISDICTION
INCOME TAX APPEAL NO.189 OF 2015
THE COMMISSIONER OF INCOME TAX-11 )...APPELLANT
V/s.
M/S.AVENTIS PHARMA LTD.)...RESPONDENT
Mr.Arvind Pinto, Advocate for the Appellant.Mr.Sanjiv Shah, Advocate for the Respondent.
CORAM:S.V.GANGAPURWALA &A. M. BADAR, JJ.DATE:31[st] JULY 2017
P.C. :
1This appeal pertains to Assessment Year 2001-2002. The learned counsel for the appellant and the respondent are ad-idem that the questions raised in the present appeal were subject matter of consideration in Income Tax appeal bearing no.1746 of 2014 for the assessment year 2000-01 and the same is dismissed by this court on 12[th] July 2017.
avk 1/2
2In light of the above, no substantial question of law
arises. The appeal is dismissed. No costs.
(A. M. BADAR, J.)
(S.V.GANGAPURWALA), J.)
avk 2/2
This page reproduces a public-domain court order (Section 52(1)(q)(iv), Copyright Act 1957). Explanations are EaseValue's original analysis. Always read the original order.
Disclaimer: General information only — not legal, tax or professional advice, and no advocate/CA–client relationship is created. AI-generated summaries may contain errors and must be verified against the original court order. EaseValue accepts no liability for reliance on this content. Not a solicitation.
Full disclaimer & Terms.
EaseValue